Showing 1 - 3 results of 3 for search 'Shangze Xu', query time: 0.01s Refine Results
  1. 1
    ‘Druggability’ of the Per–Arnt–Sim (PAS) domains of human PAS domain kinase, a therapeutic target for metabolic and liver disorders

    ‘Druggability’ of the Per–Arnt–Sim (PAS) domains of human PAS domain kinase, a therapeutic target for metabolic and liver disorders by Shangze Xu, Lanyu Fan, Piotr Zaborniak, Ruidi Zhu, Haoyuan Ji, Kate S. Harris, João V. de Souza, Agnieszka K. Bronowska

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

    Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding by Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, Richard A. Noble, Sara Pintar, Lan Z. Wang, Shangze Xu, Andrew Lister, Richard A. Ward, Agnieszka K. Bronowska, Martin E. M. Noble, Hannah L. Stewart, Michael J. Waring

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Author Correction: Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

    Author Correction: Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding by Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, Richard A. Noble, Sara Pintar, Lan Z. Wang, Shangze Xu, Andrew Lister, Richard A. Ward, Agnieszka K. Bronowska, Martin E. M. Noble, Hannah L. Stewart, Michael J. Waring

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: